Wilson C, Pommier G, Richman D, Sambold N, Hussmann J, Weissman J
bioRxiv. 2024; .
PMID: 39554033
PMC: 11565746.
DOI: 10.1101/2024.10.28.620517.
Sang Y, Xu L, Bao Z
Mol Ther. 2024; 32(12):4208-4234.
PMID: 39473180
PMC: 11638881.
DOI: 10.1016/j.ymthe.2024.10.029.
Kantor B, ODonovan B, Rittiner J, Hodgson D, Lindner N, Guerrero S
Nat Commun. 2024; 15(1):7259.
PMID: 39179542
PMC: 11344155.
DOI: 10.1038/s41467-024-50515-6.
Yun S, Noh M, Yu J, Kim H, Hui C, Lee H
Mol Cells. 2024; 47(8):100092.
PMID: 39019219
PMC: 11345568.
DOI: 10.1016/j.mocell.2024.100092.
Oh Y, Gwon L, Lee H, Hur J, Park K, Kim K
Gene Ther. 2024; 31(7-8):358-365.
PMID: 38918512
DOI: 10.1038/s41434-024-00458-w.
SETDB1 deletion causes DNA demethylation and upregulation of multiple zinc-finger genes.
Kang Y, Eom J, Min B, Park J
Mol Biol Rep. 2024; 51(1):778.
PMID: 38904842
PMC: 11192681.
DOI: 10.1007/s11033-024-09703-2.
CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments.
Laurent M, Geoffroy M, Pavani G, Guiraud S
Cells. 2024; 13(10.
PMID: 38786024
PMC: 11119143.
DOI: 10.3390/cells13100800.
Design of Oscillatory Networks through Post-Translational Control of Network Components.
Jayanthi B, Jayanthi S, Segatori L
Synth Biol Eng. 2024; 1(1).
PMID: 38590452
PMC: 11000592.
DOI: 10.35534/sbe.2023.10004.
Four classic "de novo" genes all have plausible homologs and likely evolved from retro-duplicated or pseudogenic sequences.
Hannon Bozorgmehr J
Mol Genet Genomics. 2024; 299(1):6.
PMID: 38315248
DOI: 10.1007/s00438-023-02090-6.
Engineering approaches for RNA-based and cell-based osteoarthritis therapies.
DeJulius C, Walton B, Colazo J, dArcy R, Francini N, Brunger J
Nat Rev Rheumatol. 2024; 20(2):81-100.
PMID: 38253889
PMC: 11129836.
DOI: 10.1038/s41584-023-01067-4.
Human Endogenous Retroviruses in Diseases.
Fan T, Cui J
Subcell Biochem. 2023; 106:403-439.
PMID: 38159236
DOI: 10.1007/978-3-031-40086-5_15.
Synthetic Gene Circuits for Regulation of Next-Generation Cell-Based Therapeutics.
Teixeira A, Fussenegger M
Adv Sci (Weinh). 2023; 11(8):e2309088.
PMID: 38126677
PMC: 10885662.
DOI: 10.1002/advs.202309088.
SUMOylation of Bonus, the homolog of Transcription Intermediary Factor 1, safeguards germline identity by recruiting repressive chromatin complexes to silence tissue-specific genes.
Godneeva B, Ninova M, Fejes-Toth K, Aravin A
Elife. 2023; 12.
PMID: 37999956
PMC: 10672805.
DOI: 10.7554/eLife.89493.
Single-cell chromatin state transitions during epigenetic memory formation.
Fujimori T, Rios-Martinez C, Thurm A, Hinks M, Doughty B, Sinha J
bioRxiv. 2023; .
PMID: 37873344
PMC: 10592931.
DOI: 10.1101/2023.10.03.560616.
Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities.
Muller-Dott S, Tsirvouli E, Vazquez M, Ramirez Flores R, Badia-I-Mompel P, Fallegger R
Nucleic Acids Res. 2023; 51(20):10934-10949.
PMID: 37843125
PMC: 10639077.
DOI: 10.1093/nar/gkad841.
CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation.
Cai R, Lv R, Shi X, Yang G, Jin J
Int J Mol Sci. 2023; 24(19).
PMID: 37834313
PMC: 10573330.
DOI: 10.3390/ijms241914865.
CRISPR interference to evaluate modifiers of -mediated toxicity in FTD.
Pickles S, Zanetti Alepuz D, Koike Y, Yue M, Tong J, Liu P
Front Cell Dev Biol. 2023; 11:1251551.
PMID: 37614226
PMC: 10443592.
DOI: 10.3389/fcell.2023.1251551.
Shared Gene Targets of the ATF4 and p53 Transcriptional Networks.
Baniulyte G, Durham S, Merchant L, Sammons M
Mol Cell Biol. 2023; 43(8):426-449.
PMID: 37533313
PMC: 10448979.
DOI: 10.1080/10985549.2023.2229225.
KRAB-ZFPs and cancer stem cells identity.
Olechnowicz A, Oleksiewicz U, Machnik M
Genes Dis. 2023; 10(5):1820-1832.
PMID: 37492743
PMC: 10363567.
DOI: 10.1016/j.gendis.2022.03.013.
Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer.
Li S, He X, Wang Y, Chen W, Sun R, Tian S
Genes Dis. 2023; 10(2):568-582.
PMID: 37223530
PMC: 10201600.
DOI: 10.1016/j.gendis.2021.12.019.